Cited by 89Posttraumatic Stress Disorder ResearchMigration, Health and TraumaTreatment of Major Depression

Sertraline, Paroxetine, and Venlafaxine in refugee posttraumatic stress disorder with depression symptoms

Smajkic, Amer, Weine, Stevan, Djuric‐Bijedic, Zvezdana, Boskailo, Esad, Lewis, Jonathan, Pavkovic, Ivan·2001·Journal of Traumatic Stress

Abstract

Three new antidepressants were used in treating posttraumatic stress disorder (PTSD) and symptoms of depression in Bosnian refugees. Thirty‐two Bosnian refugees seeking treatment at a mental health clinic participated in a case series study. All received open trials of Sertraline (n = 15), Paroxetine (n = 12), or Venlafaxine (n = 5), with standard clinical doses. Overall, Sertraline and Paroxetine produced statistically significant improvement at 6 weeks in PTSD symptom severity, in depression, and in Global Assessment of Functioning. Venlafaxine produced improvement in PTSD symptom severity and in Global Assessment of Functioning did not yield improvement in symptoms of major depressive disorder, and had a high rate of side effects. Notwithstanding improvement of symptoms, all 32 refugees remained PTSD positive at the diagnostic level at the 6‐week follow‐up.

Integrity signals

Registry

Crossref · 10.1023/a:1011177420069

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

The citation lists haven’t been fetched yet

References 13 · Cited by 89

Authors
Smajkic, A., Weine, S., Djuric‐Bijedic, Z., Boskailo, E., Lewis, J., & Pavkovic, I.
Affiliations
  • University of Illinois Chicago (US)
  • Heartland Alliance (US)
Corresponding author
  • Smajkic, Amer
  • Weine, Stevan
Venue
Journal of Traumatic Stress
Publisher
Wiley
Published
2001-07
Volume
14
Issue
3
Pages
445-452
ISSN
  • 0894-9867 (ISSN-L)
  • 1573-6598
OpenAlex
W2090846151
Cited by
89
References
13
Citations by year
2026: 2 · 2025: 1 · 2024: 4 · 2023: 1 · 2022: 4 · 2021: 4 · 2020: 4 · 2019: 1 · 2018: 2 · 2017: 1 · 2016: 2 · 2015: 3 · 2014: 5 · 2013: 2 · 2012: 6
FWCI
8.43
Type
journal article
Language
en
Open access
closed
Locations
  • Journal of Traumatic Stress (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Social Sciences › Psychology › Clinical Psychology › Posttraumatic Stress Disorder Research
  • Social Sciences › Psychology › Clinical Psychology › Migration, Health and Trauma
  • Health Sciences › Medicine › Pharmacology › Treatment of Major Depression
Keywords
sertraline, paroxetine, venlafaxine, post-traumatic stress disorder, depression, Bosnian refugees, ethnic cleansing, antidepressants, PTSD symptom severity, Global Assessment of Functioning, adverse drug reactions
MeSH terms
Venlafaxine Hydrochloride, Adult, Cyclohexanols, Depression, Female, Humans, Male, Middle Aged, Psychiatric Status Rating Scales, Surveys and Questionnaires, Refugees, Severity of Illness Index, Stress Disorders, Post-Traumatic, Treatment Outcome, Selective Serotonin Reuptake Inhibitors, Paroxetine, Sertraline

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review